Loading data for ASTH — first visit, this takes a few seconds.

Alerta

Astrana Health Inc. (ASTH)

NasdaqCM: ASTH · Precio en tiempo real · USD

39.52

+0.36 (0.92%)

Al cierre: Aug 19, 2026, 7:34 PM

0.92% (1D)

No hay datos disponibles

Precio de compra	29.05
Capitalización de mercado	1.96B
Ingresos (TTM)	3.84B
Beneficio neto (TTM)	40.55M
Beta	0.90
EPS (TTM)	0.82
Ratio PER (TTM)	48.2
Adelante PE	11.17
P/B (TTM)	2.34
P/S (TTM)	0.51
Earnings Date	Nov 5, 2026

Precio de venta	50.32
Volumen	184,143
Volumen medio (20D)	611,203
Abierto	39.71
Anterior Cerrar	39.16
Rango del día	39.13 - 41.00
Rango de 52 semanas	18.08 - 51.60
analista	n/a
Precio objetivo	n/a
Dividendos	n/a
Fecha ex dividendo	n/a

Acerca de ASTH

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care ...

[Leer más]

Industria Medical Care Facilities

Sector Healthcare

IPO Fecha Mar 11, 2009

Empleados 3,000

Bolsa de Valores NasdaqCM

Símbolo bursátil ASTH

Sitio web https://www.astranahealth.com

Perfil completo de la empresa

Desempeño financiero

En 2025, los ingresos de Astrana Health fueron 3.18B, un aumento de 56.39% en comparación con 2.03B del año anterior. Las ganancias fueron 22.49M, una disminución de -47.89%.

Estados financieros

Sorpresa de resultados

Astrana Health ha publicado sus resultados trimestrales en Aug 6, 2026:

Ingresos de n/a falla las estimaciones por $0, con -100.00% Disminución interanual.

EPS de 0.8 supera las estimaciones en 0.07, con 37.93% Crecimiento interanual.

Próxima publicación de resultados

Está previsto que Astrana Health Inc. publique sus resultados el Nov 5, 2026, durante el horario de mercado.
Los analistas proyectan ingresos de ... Actualizar

Noticias

5 días hace · Motley Fool

Astrana Health (ASTH) Q2 2026 Earnings Call Transcript

Revenue jumped 49% to $972.5 million as adjusted EPS hit record $0.80.

1 semana hace · StockStory

ASTH Q2 Deep Dive: AI-Driven Operating Leverage and Strategic Expansion Shape Outlook

Healthcare services company Astrana Health missed Wall Street’s revenue expectations in Q2 CY2026, but sales rose 48.5% year on year to $972.5 million. Next quarter’s revenue guidance of $1.02 billion...

1 semana hace · Simply Wall St.

Astrana Health (ASTH) Stock Sees Modest Fair Value Lift As Analysts Back Integration Progress

Astrana Health now sits on a modestly higher fair value estimate, with the modeled price moving from about US$47.11 to about US$50.13 per share. That shift lines up with analyst commentary that weighs...

1 semana hace · GuruFocus.com

Astrana Health Inc (ASTH) (Q2 2026) Earnings Call Highlights: Record EPS and Raised Guidance ...

Astrana Health Inc (ASTH) delivers 49% revenue growth and raises full-year adjusted EBITDA guidance to $255-$280 million.

1 semana hace · Zacks

Astrana Health, Inc. (ASTH) Q2 Earnings Top Estimates

Astrana Health, Inc. (ASTH) delivered earnings and revenue surprises of +29.03% and -0.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Página 1 de 2

Astrana Health Inc. (ASTH)